Skip to content
★ Sign in to follow
BP

Bafna Pharmaceuticals Limited Stock: price and insider trades · India

IN·Mcap ₹9.9BHealth Care

Bafna Pharmaceuticals Limited: what insiders have been doing

This page follows insider dealings at Bafna Pharmaceuticals Limited as filed with SEBI (PIT + SAST), a company from the Health Care sector. Bafna Pharmaceuticals Limited has had no insider filing for more than a year; the last one goes back to 29 March 2025.

Our records for Bafna Pharmaceuticals Limited go back to 2021, with no purchases and 6 sales on the open market in total.

In the same sector, recent insider purchases at Anixa Biosciences Inc and Vivos Inc also feature in our signals. These figures are compiled from regulatory filings published by SEBI (PIT + SAST). They describe what insiders did and are not a recommendation.

Insider Decl.
14
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€122,938
6 ops. · all time

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 17,641 of 26,912 companies
41.4
score / 100
Value
24
Quality
59
FCF yld-0.9%
Earn yld1.0%
EV/EBITDA56.0x
ROE12%
Gross mgn32%
Net mgn7.4%
Debt/EBITDA1.8x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2026

FY ended March 2026 · cache

₹418.00
Analyst consensus
·
Income statement
Revenue₹1.5B
Gross profit₹481.3M32% margin
EBITDA₹205.4M14% margin
Net income₹111M5.5% margin
Valuation
PER (trailing)127.1x
P/Book10.3x
Beta0.07
Balance sheet & cash
Market cap₹9.9B
Total debt₹374.3M
Free Cash Flow-₹95.3M
Debt / Equity39%
Profitability & ownership
ROE12.3%
ROA3.8%
% insiders89.7%
% institutions0.0%
Last declaration on 29 March 2025
Declarations14 total
  • ●
    Related company / holdingExecutives
    204M INR10SEBI
    2,830,766 shares@ ₹72.0085.8% of flowEquity SharesSEBI:762be6eb55b98aa2d22dfeada2aecaa16187f3f1
  • ●
    Related company / holdingExecutives
    23M INR3SEBI
    314,530 shares@ ₹72.009.5% of flowEquity SharesSEBI:ff57d4bbed4f931520044f4bf046e89257fa0195
  • ▼
    Related company / holdingExecutives
    916,568 INR2SEBI
    8,897 shares@ ₹103.01990.4% of flowEquity SharesSEBI:df736f9e5ca6cc3f0a1deb173f7120f4ec5b978e
  • ▼
    Related company / holdingExecutives
    1M INR2SEBI
    9,883 shares@ ₹109.67240.5% of flowEquity SharesSEBI:56c8b9659710f0e6e839bf01326478b40ad0cd03
  • ▼
    Related company / holdingExecutives
    3M INR2SEBI
    27,218 shares@ ₹123.03021.6% of flowEquity SharesSEBI:2487d88c41b09265b162fed6ab2227efa69c125a
  • ▼
    Related company / holdingExecutives
    2M INR2SEBI
    13,135 shares@ ₹127.000.8% of flowEquity SharesSEBI:20724b518edc8382a271ae5dd3ceb80f8d19da9f
  • ▼
    Related company / holdingExecutives
    1M INR2SEBI
    11,123 shares@ ₹123.000.6% of flowEquity SharesSEBI:ba398ba46904faae0655c1c6be01bd7378fd1369
  • ▼
    Related company / holdingExecutives
    2M INR2SEBI
    14,756 shares@ ₹118.61920.8% of flowEquity SharesSEBI:63fc2b856b2449cdb77caf30cfca2a33ff06fd96
  • ●
    Executives
    0SEBI
    148,507 sharesEquity SharesSEBI:70974be660fb4b1c83cedaccab096ca003af0abb
  • ●
    Related company / holdingExecutives
    0SEBI
    15,823 sharesEquity SharesSEBI:5842e7626989fb2ee58f4e678cc71d2a6879bcac
  • ●
    Executives
    0SEBI
    41,167 sharesEquity SharesSEBI:0a188bb12ba7de1a37976e6675738ad7110adeb8
  • ●
    Executives
    0SEBI
    50,000 sharesEquity SharesSEBI:d1a083a77c7cfedec90ce1d46f0775fd62e535d4
  • ●
    Executives
    0SEBI
    62,757 sharesEquity SharesSEBI:6a9f61adbae16e9af738c5a75b111280ba7c5f40
  • ●
    Executives
    0SEBI
    213,280 sharesEquity SharesSEBI:c54ed56661d0cf10164fa6c53cfba29fb5e7099d

14 of 14 declarations

About Bafna Pharmaceuticals Limited

Bafna Pharmaceuticals Limited is a company engaged in the manufacturing of pharmaceutical products. It is listed on the XBOM market.